<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hoseini SS</submitter><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>1530-42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4607259</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(7)</volume><pubmed_abstract>Co-transplantation of hematopoietic stem cells with those engineered to express leukemia-reactive T-cell receptors (TCRs) and differentiated ex vivo into precursor T cells (preTs) may reduce the risk of leukemia relapse. As expression of potentially self-(leukemia-) reactive TCRs will lead to negative selection or provoke autoimmunity upon thymic maturation, we investigated a novel concept whereby TCR expression set under the control of an inducible promoter would allow timely controlled TCR expression. After in vivo maturation and gene induction, preTs developed potent anti-leukemia effects. Engineered preTs provided protection even after repeated leukemia challenges by giving rise to effector and central memory cells. Importantly, adoptive transfer of TCR-transduced allogeneic preTs medi</pubmed_abstract><journal>Leukemia</journal><pubmed_title>Inducible T-cell receptor expression in precursor T cells for leukemia control.</pubmed_title><pmcid>PMC4607259</pmcid><funding_grant_id>P01 CA065493</funding_grant_id><funding_grant_id>R01 CA72669</funding_grant_id><funding_grant_id>R01 CA072669</funding_grant_id><funding_grant_id>R01 HL056067</funding_grant_id><pubmed_authors>Heinz N</pubmed_authors><pubmed_authors>Herbst J</pubmed_authors><pubmed_authors>Vignali DA</pubmed_authors><pubmed_authors>Wedekind D</pubmed_authors><pubmed_authors>Baumann R</pubmed_authors><pubmed_authors>Blazar BR</pubmed_authors><pubmed_authors>van den Brink MR</pubmed_authors><pubmed_authors>Schambach A</pubmed_authors><pubmed_authors>Schiedlmeier B</pubmed_authors><pubmed_authors>Hapke M</pubmed_authors><pubmed_authors>Hoseini SS</pubmed_authors><pubmed_authors>Sauer MG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inducible T-cell receptor expression in precursor T cells for leukemia control.</name><description>Co-transplantation of hematopoietic stem cells with those engineered to express leukemia-reactive T-cell receptors (TCRs) and differentiated ex vivo into precursor T cells (preTs) may reduce the risk of leukemia relapse. As expression of potentially self-(leukemia-) reactive TCRs will lead to negative selection or provoke autoimmunity upon thymic maturation, we investigated a novel concept whereby TCR expression set under the control of an inducible promoter would allow timely controlled TCR expression. After in vivo maturation and gene induction, preTs developed potent anti-leukemia effects. Engineered preTs provided protection even after repeated leukemia challenges by giving rise to effector and central memory cells. Importantly, adoptive transfer of TCR-transduced allogeneic preTs medi</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2025-04-04T01:29:09.685Z</modification><creation>2019-03-27T02:00:08Z</creation></dates><accession>S-EPMC4607259</accession><cross_references><pubmed>25652739</pubmed><doi>10.1038/leu.2015.20</doi></cross_references></HashMap>